Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 20;6(6):CD011177.
doi: 10.1002/14651858.CD011177.pub3.

Zinc supplementation for the treatment of measles in children

Ajibola A Awotiwon  1 , Olabisi Oduwole, Anju Sinha, Charles I Okwundu
Affiliations

Zinc supplementation for the treatment of measles in children

Ajibola A Awotiwon et al. Cochrane Database Syst Rev. .

Abstract

Background: Measles is an important cause of childhood morbidity and mortality globally, despite increasing vaccine coverage. Zinc plays a significant role in the maintenance of normal immunological functions, therefore supplements given to zinc-deficient children will increase the availability of zinc and could reduce measles-related morbidity and mortality. This is an update of a review first published in 2015.

Objectives: To assess the effects of zinc supplementation in reducing morbidity and mortality in children with measles.

Search methods: We searched CENTRAL (03 February 2017, Issue 2), MEDLINE (1946 to 03 February 2017), Embase (1974 to 03 February 2017), CINAHL (1981 to 03 February 2017), LILACS (1982 to 03 February 2017), Web of Science (1985 to 03 February 2017), and BIOSIS Previews (1985 to 27 June 2014). We also searched ClinicalTrials.gov, the Australian New Zealand Clinical Trials Registry and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) on 03 February 2017 to identify unpublished and ongoing studies.

Selection criteria: Randomised controlled trials (RCTs) and quasi-RCTs evaluating the effects of zinc in reducing morbidity and mortality in children with measles.

Data collection and analysis: Two review authors independently assessed the studies for inclusion and extracted data on outcomes, details of the interventions, and other study characteristics using a standardised data extraction form. We used risk ratio (RR) and hazard ratio (HR) as measures of effect with 95% confidence intervals (CI). We included only one study, and did not conduct meta-analysis.

Main results: We did not identify any new studies for inclusion in this update. One RCT met our inclusion criteria. The study was conducted in India and included 85 children diagnosed with measles and pneumonia. The trial showed no significant difference in mortality between children with measles and pneumonia who received zinc supplements and those who received placebo (RR 0.34, 95% CI 0.01 to 8.14). There was no significant difference in time to absence of fever between children who received zinc supplements and those who did not (HR 1.08, 95% CI 0.67 to 1.74). No treatment-related side effects were reported in either group. We assessed the overall quality of the evidence as very low.

Authors' conclusions: We could not draw any definitive conclusions from this review about the effects of zinc supplementation on clinical outcomes of children with measles due to the very low quality of the evidence available. There is insufficient evidence to confirm or refute the effect of zinc supplementation in children with measles.

PubMed Disclaimer

Conflict of interest statement

Ajibola Awotiwon: none known. Olabisi Oduwole: none known. Anju Sinha: none known. Charles Okwundu: none known.

Figures

1
1
Study flow diagram.
2
2
'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
3
3
Forest plot of comparison: 1 Zinc versus placebo, outcome: 1.1 Mortality.
4
4
Forest plot of comparison: 1 Zinc versus placebo, outcome: 1.2 Time to fever abatement.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Mahalanabis 2002 {published data only}
    1. Khaled MA, Mahalanabis D, Jana S, Chowdhury MK, Haque KM, Das KP. Zinc supplementation and lipid peroxidation in children with measles and pneumonia. FASEB Journal 2001;15:A610.
    1. Mahalanabis D, Chowdhury A, Jana S, Bhattacharya MK, Chakrabarti MK, Wahed MA, et al. Zinc supplementation as adjunct therapy in children with measles accompanied by pneumonia: a double‐blind, randomized controlled trial. American Journal of Clinical Nutrition 2002;76(3):604‐7. [PUBMED: 12198006] - PubMed
    1. Mahalanabis D, Chowdhury A, Jana S, Bhattacharya MK, Chakrabarty MK, Wahed MA, et al. Zinc supplementation of children suffering from measles with pneumonia: effect on diseases severity. FASEB Journal 2001;15(5):A1094.

References to studies excluded from this review

Tielsch 2007 {published data only}
    1. Tielsch JM, Khatry SK, Stoltzfus RJ, Katz J, LeClerq SC, Adhikari R, et al. Effect of daily zinc supplementation on child mortality in southern Nepal: a community‐based, cluster randomised, placebo‐controlled trial. Lancet 2007;370(9594):1230‐9. [PUBMED: 17920918] - PMC - PubMed

Additional references

Aggarwal 2007
    1. Aggarwal R, Sentz J, Miller MA. Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta‐analysis. Pediatrics 2007;119(6):1120‐30. [PUBMED: 17545379] - PubMed
Atkins 2004
    1. Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490. - PMC - PubMed
Bach 1989
    1. Bach JF, Dardenne M. Thymulin, a zinc‐dependent hormone. Medical Oncology and Tumor Pharmacotherapy 1989;6(1):25‐9. [PUBMED: 2657247] - PubMed
Bhutta 1999
    1. Bhutta ZA, Black RE, Brown KH, Gardner JM, Gore S, Hidayat A, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. Journal of Pediatrics 1999;135(6):689‐97. [PUBMED: 10586170] - PubMed
Carrillo‐Santisteve 2012
    1. Carrillo‐Santisteve P, Lopalco PL. Measles still spreads in Europe: who is responsible for the failure to vaccinate?. Clinical Microbiology and Infection 2012;18(Suppl 5):50‐6. [PUBMED: 23051058] - PubMed
Cuevas 2005
    1. Cuevas LE, Koyanagi A. Zinc and infection: a review. Annals of Tropical Paediatrics 2005;25(3):149‐60. [PUBMED: 16156979] - PubMed
GRADEpro GDT 2014 [Computer program]
    1. GRADE Working Group, McMaster University. GRADEpro GDT. Version (accessed October 2014). Hamilton (ON): GRADE Working Group, McMaster University, 2014.
Gulani 2014
    1. Gulani A, Sachdev HS. Zinc supplements for preventing otitis media. Cochrane Database of Systematic Reviews 2014, Issue 6. [DOI: 10.1002/14651858.CD006639.pub4] - DOI - PMC - PubMed
Haase 2009
    1. Haase H, Rink L. Functional significance of zinc‐related signaling pathways in immune cells. Annual Review of Nutrition 2009;29:133‐52. [PUBMED: 19400701] - PubMed
Haider 2011
    1. Haider BA, Lassi ZS, Ahmed A, Bhutta ZA. Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD007368.pub2] - DOI - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Lassi 2016
    1. Lassi ZS, Moin A, Bhutta ZA. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. Cochrane Database of Systematic Reviews 2016, Issue 12. [DOI: 10.1002/14651858.CD005978.pub3] - DOI - PMC - PubMed
Lazzerini 2016
    1. Lazzerini M, Wanzira H. Oral zinc for treating diarrhoea in children. Cochrane Database of Systematic Reviews 2016, Issue 12. [DOI: 10.1002/14651858.CD005436.pub5] - DOI - PMC - PubMed
Lefebvre 2011
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Mason 2016
    1. Mason WH. Measles. In: Kliegman RM, Stanton BF, Geme JW, Shor NF editor(s). Nelson Textbook of Pediatrics. 20th Edition. Elsevier Science (USA), 2016.
Perry 2004
    1. Perry RT, Halsey NA. The clinical significance of measles: a review. Journal of Infectious Diseases 2004;189(Suppl 1):4‐16. [PUBMED: 15106083] - PubMed
Prasad 1998
    1. Prasad AS. Zinc and immunity. Molecular and Cellular Biochemistry 1998;188(1‐2):63‐9. [PUBMED: 9823012] - PubMed
Prasad 2000
    1. Prasad AS. Effects of zinc deficiency on immune functions. Journal of Trace Elements in Experimental Medicine 2000;13(1):1‐20.
Prasad 2009
    1. Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Current Opinion in Clinical Nutrition and Metabolic Care 2009;12(6):646‐52. [PUBMED: 19710611] - PubMed
RevMan 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5. Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Roth 2008
    1. Roth DE, Caulfield LE, Ezzati M, Black RE. Acute lower respiratory infections in childhood: opportunities for reducing the global burden through nutritional interventions. Bulletin of the World Health Organization 2008;86(5):356‐64. [PUBMED: 18545738] - PMC - PubMed
Sartorius 2013
    1. Sartorius B, Cohen C, Chirwa T, Ntshoe G, Puren A, Hofman K. Identifying high‐risk areas for sporadic measles outbreaks: lessons from South Africa. Bulletin of the World Health Organization 2013;91(3):174‐83. [PUBMED: 23476090] - PMC - PubMed
Sazawal 1998
    1. Sazawal S, Black RE, Jalla S, Mazumdar S, Sinha A, Bhan MK. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double‐blind, controlled trial. Pediatrics 1998;102:1‐5. - PubMed
Sazawal 2007
    1. Sazawal S, Black RE, Ramsan M, Chwaya HM, Dutta A, Dhingra U, et al. Effect of zinc supplementation on mortality in children aged 1‐48 months: a community‐based randomised placebo‐controlled trial. Lancet 2007;369(9565):927‐34. [PUBMED: 17368154] - PubMed
Schünemann 2011
    1. Schünemann HJ, Oxman AD, Vist GE, Higgins JP, Deeks JJ, Glasziou P. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Shakur 2009
    1. Shakur MS, Malek MA, Bano N, Rahman M, Ahmed M. Serum and hair zinc in severely malnourished Bangladeshi children associated with or without acute lower respiratory infection. Indian Journal of Pediatrics 2009;76(6):609‐14. [PUBMED: 19381511] - PubMed
Simons 2012
    1. Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet 2012;379(9832):2173‐8. [PUBMED: 22534001] - PubMed
Stefanidou 2006
    1. Stefanidou M, Maravelias C, Dona A, Spiliopoulou C. Zinc: a multipurpose trace element. Archives of Toxicology 2006;80(1):1‐9. [PUBMED: 16187101] - PubMed
Tapiero 2003
    1. Tapiero H, Tew KD. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomedicine and Pharmacotherapy 2003;57(9):399‐411. [PUBMED: 14652165] - PubMed
Tuerk 2009
    1. Tuerk MJ, Fazel N. Zinc deficiency. Current Opinion in Gastroenterology 2009;25(2):136‐43. [PUBMED: 19528881] - PubMed
WHO 2004
    1. World Health Organization. Treating measles in children. www.who.int/immunization_delivery/interventions/TreatingMeaslesENG300.pdf 2004 (accessed 27 November 2013).
WHO 2012
    1. World Health Organization. Global measles and rubella strategic plan: 2012 ‐ 2020. Geneva: World Health Organization, 2012.
WHO/UNICEF 2004
    1. World Health Organization. Department of Child and Adolescent Health and Development/United Nations International Children's Emergency Fund. Clinical management of acute diarrhoea: WHO/UNICEF joint statement [WHO/FCH/CAH/04.7; UNICEF/PD/Diarrhoea/01]. whqlibdoc.who.int/hq/2004/WHO_FCH_CAH_04.7.pdf 2004 (accessed 27 November 2013).
Wolfson 2009
    1. Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality ratios: a comprehensive review of community‐based studies. International Journal of Epidemiology 2009;38(1):192‐205. - PubMed
World Bank 2016
    1. International Bank for Reconstruction and Development. World Bank list of economies. www.ispo2017.org/wp‐content/uploads/2016/11/World‐Bank‐List‐of‐Economies... 2016 (accessed 10 May 2017).
Wuehler 2005
    1. Wuehler SE, Peerson JM, Brown KH. Use of national food balance data to estimate the adequacy of zinc in national food supplies: methodology and regional estimates. Public Health Nutrition 2005;8(7):812‐9. [PUBMED: 16277796] - PubMed

References to other published versions of this review

Awotiwon 2014
    1. Awotiwon AA, Oduwole O, Sinha A, Okwundu CI. Zinc supplementation for the treatment of measles in children. Cochrane Database of Systematic Reviews 2014, Issue 6. [DOI: 10.1002/14651858.CD011177] - DOI - PMC - PubMed
Awotiwon 2015
    1. Awotiwon AA, Oduwole O, Sinha A, Okwundu CI. Zinc supplementation for the treatment of measles in children. Cochrane Database of Systematic Reviews 2015, Issue 3. [DOI: 10.1002/14651858.CD011177.pub2] - DOI - PubMed

Publication types

LinkOut - more resources